AFW Stock Chart & Stats
€163.30
-€2.30(-1.09%)
At close: 4:00 PM EST
€163.30
-€2.30(-1.09%)
Day’s Range― - ―
52-Week Range€105.40 - €177.85
Previous CloseN/A
Volume0.00
Average Volume (3M)6.00
Market Cap
€11.55B
Enterprise Value€11.48B
Total Cash (Recent Filing)€1.06B
Total Debt (Recent Filing)€116.04M
Price to Earnings (P/E)30.9
Beta0.98
Next Earnings
Jul 29, 2026EPS Estimate
2.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.97
Shares Outstanding71,618,126
10 Day Avg. Volume0
30 Day Avg. Volume6
Financial Highlights & Ratios
PEG Ratio51.77
Price to Book (P/B)2.80
Price to Sales (P/S)2.81
P/FCF Ratio23.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€182.72Price Target Upside11.89% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
EPS Forecast (FY)9.8
Revenue Forecast (FY)€3.60B
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet / Low LeverageVery low leverage and a growing equity base give Align durable financial flexibility. This reduces refinancing and solvency risk, supports continued R&D, capital expenditures, M&A optionality and share repurchases, and helps absorb shocks such as legal or geopolitical costs.
High Gross Margins And Improving Operating ProfitabilitySustained high gross margins and recent operating-margin expansion underpin durable earnings power. Strong product-level economics give pricing and reinvestment capacity, supporting R&D and go-to-market spend while enabling cash returns and resilience to moderate volume swings.
Large ITero Installed Base And Ecosystem AdvantagesA large scanner installed base creates network effects and recurring systems revenue. iTero scale strengthens doctor workflows, increases cross-sell of software/consumables and makes Align’s platform stickier, supporting multi-year case submissions and higher lifetime customer value.
Bears Say
EU Antitrust Investigation (regulatory Risk)A formal EU probe into scanner interoperability is a structural regulatory risk. Potential remedies, fines or mandated interoperability could force changes to Align’s scanner and scan-acceptance model, reducing competitive leverage, altering systems revenue and complicating long-term commercial strategy.
Input-cost Exposure To Resin/plasticsMaterial exposure of COGS to resin/plastics ties gross margin to oil-based input prices. Persistent or rising resin costs can compress margins absent offsetting price increases, adding structural volatility to profitability and making margin guidance and cash flow less predictable.
Elevated Receivables And Uneven Cash ConversionHigh receivables and 97-day DSO tie up working capital and constrain free-cash-flow flexibility. Historical volatility in cash conversion increases funding needs during slower growth periods and can limit the pace of buybacks, capex or opportunistic investments over the medium term.
AFW FAQ
What was Align Technology’s price range in the past 12 months?
Align Technology lowest stock price was €105.40 and its highest was €177.85 in the past 12 months.
What is Align Technology’s market cap?
Align Technology’s market cap is €11.55B.
When is Align Technology’s upcoming earnings report date?
Align Technology’s upcoming earnings report date is Jul 29, 2026 which is in 25 days.
How were Align Technology’s earnings last quarter?
Align Technology released its earnings results on Apr 29, 2026. The company reported €2.255 earnings per share for the quarter, beating the consensus estimate of €2.006 by €0.249.
Is Align Technology overvalued?
According to Wall Street analysts Align Technology’s price is currently Undervalued.
Does Align Technology pay dividends?
Align Technology does not currently pay dividends.
What is Align Technology’s EPS estimate?
Align Technology’s EPS estimate is 2.3.
How many shares outstanding does Align Technology have?
Align Technology has 71,618,126 shares outstanding.
What happened to Align Technology’s price movement after its last earnings report?
Align Technology reported an EPS of €2.255 in its last earnings report, beating expectations of €2.006. Following the earnings report the stock price went down -1.881%.
Which hedge fund is a major shareholder of Align Technology?
Currently, no hedge funds are holding shares in DE:AFW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Align Tech Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€182.72 (11.89% Upside)
€182.72 (11.89% Upside)
Blogger Sentiment
Neutral
DE:AFW Sentiment 50%
Sector Average ―
Sector Average ―
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-6.32%
12-Months-Change
Fundamentals
Return on Equity
10.70%
Trailing 12-Months
Asset Growth
3.46%
Trailing 12-Months
Company Description
Align Technology
Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.
AFW Company Deck
AFW Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated strong operational and financial performance: record Clear Aligner volumes, broad international growth, margin expansion, EPS and cash generation, and traction for commercial and product initiatives (DSP, financing, iTero/exocad integration). Management reiterated full-year guidance while taking a prudent stance given geopolitical uncertainty and flagged near-term risks (North America softness, Systems & Services seasonality, higher OpEx and resin/freight exposure). On balance the positives — robust volume growth, improving margins, product/platform momentum and capital returns — outweigh the challenges, though the company remains cautious on macro risks.View all DE:AFW earnings summariesAFW Revenue Breakdown
80.43% Clear Aligner
19.57% Systems and Services

AFW Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€182.72
▲(11.89% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Smith & Nephew Snats
―
Ufp Technologies
―
Zimmer Biomet Holdings
―
Globus Medical
―
Glaukos
―
Options Prices
Currently, No data available
---









